Assisted Reproductive Technology Market Outlook:
Assisted Reproductive Technology Market size was over USD 31.7 billion in 2025 and is anticipated to cross USD 62.94 billion by 2035, growing at more than 7.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of assisted reproductive technology is assessed at USD 33.73 billion.
It is believed that the rising burden of infertility is driving innovations in the field of assisted reproductive technology (ART) that covers all reproductive procedures that deal with eggs or embryos. As per the World Health Organization (WHO), approximately 1 in 6 adults globally, or 17.5% of the population, are infertile.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of assisted reproductive technology is assessed at USD 33.73 billion.
The global assisted reproductive technology market size surpassed USD 31.7 billion in 2025 and is projected to grow at a CAGR of over 7.1%, reaching USD 62.94 billion revenue by 2035.
North America assisted reproductive technology market will hold more than 35% share by 2035, fueled by rising disposable income leading to increased demand for assisted reproductive technology.
Key players in the market include Calibre Scientific, CooperSurgical, Inc., FUJIFILM Irvine Scientific, Cryolab Ltd., Bloom IVF Centre, Merck KGaA, Ferring B.V., Vitrolife AB, European Sperm Bank.
